THEOREMDX
DEAD

Serial Number

87612496

Owner

THEOREMDX INC.

Attorney

Robert P. Ziemian

Filing Date

Sep 18, 2017

Add to watchlist:

No watchlists yet
View on USPTO

THEOREMDX Trademark

Serial Number: 87612496

THEOREMDX is a trademark filed by THEOREMDX INC. on September 18, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

THEOREMDX INC. (2 trademarks)

1431 Summit Avenue
St. Paul, MN 55105

Entity Type: 03

Ovagene Oncology, Inc. (11 trademarks)

Suite 150
Irvine, CA 92618

Entity Type: 03

Trademark Details

Filing Date

September 18, 2017

Registration Date

Not Registered

Published for Opposition

July 17, 2018

Goods & Services

Scientific instruments for analyzing analytes in blood; scientific instruments for analyzing analytes in saliva; scientific instruments for analyzing analytes in urine; scientific instruments for analyzing analytes in semen; scientific instruments for analyzing analytes in bodily fluids; scientific instruments for analyzing blood samples to detect diseases; scientific instruments for analyzing saliva samples to detect diseases; scientific instruments for analyzing urine samples to detect diseases; scientific instruments for analyzing semen samples to detect diseases; scientific instruments for analyzing bodily fluid samples to detect diseases

Medical diagnostic devices for determining analytes in blood; Medical diagnostic devices for determining analytes saliva; Medical diagnostic devices for determining analytes in urine; Medical diagnostic devices for determining analytes in semen; Medical diagnostic devices for determining analytes in bodily fluids; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a blood sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a salvia sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a urine sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a semen sample; Medical diagnostic devices for diagnosing infectious diseases, cancer, cardiovascular diseases, neuro-cardiovascular diseases and immunological diseases from a bodily fluid sample

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Jun 8, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jun 8, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2019 EXRA
SOU EXTENSION 2 GRANTED
Jul 5, 2019 EX2G
SOU EXTENSION 2 FILED
Jul 5, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 5, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 1, 2019 EXRA
SOU EXTENSION 1 GRANTED
Feb 27, 2019 EX1G
SOU EXTENSION 1 FILED
Feb 27, 2019 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 27, 2019 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 17, 2018 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 17, 2018 COAR
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 11, 2018 NOAM
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 25, 2018 ASGN
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 17, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jul 17, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 27, 2018 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 14, 2018 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 11, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 11, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 11, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 11, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 11, 2018 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 4, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 4, 2018 CRFA
ASSIGNED TO LIE
May 29, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2018 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 21, 2017 GNRN
NON-FINAL ACTION E-MAILED
Dec 21, 2017 GNRT
NON-FINAL ACTION WRITTEN
Dec 21, 2017 CNRT
ASSIGNED TO EXAMINER
Dec 21, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 22, 2017 NWOS
NEW APPLICATION ENTERED
Sep 21, 2017 NWAP